Improving Outcomes in Peripheral Bypass: The role of TTFM and HFUS

Up to 20%of peripheral bypasses fail without a clear cause within the first year, and there's still no standard for completion control. While some hospitals use TTFM and HFUS routinely, there are more clinical questions to be addressed.

Join us in hearing from the lead investigator of the newly started international PATENT study, which was designed to establish evidence-based protocols and reduce graft failure in CLTI patients. You'll also gain real-world insights from a seasoned vascular surgeon using Medistim technology to improve outcomes in daily practice.

‍

Hear from:

• VP Medical Medistim Anne Waaler giving background of the PATENT study

• Professor, MD. Michael Conte, UCSF University of California, on open surgery and the value of flow and imaging

• MD. Katariina Noronen, Helsinki University Central Hospital HUCH shares case experience with TTFM and HFUS

• Live Q&A at the end